Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Subrahmanyam Talari"'
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-13 (2021)
Abstract Background A receptive and easily comprehended technique was evolved for simultaneous assessment of Bempedoic acid and Ezetimibe and its impurities characterized by UPLC–MS/MS. Results This technique involves chromatographic separation wit
Externí odkaz:
https://doaj.org/article/c0fb128f67e44466bc68c12c3ca6d36f
Autor:
Anuradha Vejendla, Subrahmanyam Talari, Raju Moturu, S. N. Murthy Boddapati, A. Emmanuel Kola
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-18 (2021)
Abstract Background Using a Symmetry C18 (4.6 × 150 mm, 3.5) column, a high-performance liquid chromatographic method for quantification of Rilpivirine and Cabotegravir in active pharmaceutical ingredients was developed and validated. The mobile pha
Externí odkaz:
https://doaj.org/article/bb740d18053343ea90a656ec5ff22414
Autor:
Mahankali Pavan Phani Kumar, Anuradha Vejendla, C. Gladis Raja Malar, Subramanyam Chennamsetty, Subrahmanyam Talari, Nagalakshmi Vedula
Publikováno v:
Phosphorus, Sulfur, and Silicon and the Related Elements. :1-14
In the present work, we have developed a greener approach to synthesize a series of novel bis(α-aminophosphonates) (bis(α-Aps)) via a microwave-mediated nano TiO2-SiO2 catalyzed Kabachnik-Fields (K-F) reaction under solvent-free conditions. An in s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f0b819b86c592671040a80f77cb69d
https://doi.org/10.1080/10426507.2023.2198715
https://doi.org/10.1080/10426507.2023.2198715
Publikováno v:
Current Pharmaceutical Analysis. 18:614-628
Background: Lenvatinib is a potent drug utilized in the medication of thyroid cancer and it acts as a tyrosine kinase inhibitor. Thus, the development and validation of Lenvatinib and allied impurities in rat plasma, and its pharmacokinetic study, ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45b217e99e331dd63e256e4fc21e7116
https://doi.org/10.2174/1573412918666220330004440
https://doi.org/10.2174/1573412918666220330004440
Publikováno v:
Chemistry Africa. 5:781-790
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c33b18b963113bf0d1635b706f46d54b
https://doi.org/10.1007/s42250-022-00347-y
https://doi.org/10.1007/s42250-022-00347-y
Publikováno v:
Current Pharmaceutical Analysis. 18:291-304
Background: Verapamil is an excellent drug used for the medication of hypertension and trandolapril. It is an angiotensin-converting-enzyme inhibitor. Hence, it is an interesting method to develop a novel and reliable MS/UPLC strategy for the simulta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bcd560c5f059d37874ccf86197431ebd
https://doi.org/10.2174/1573412917666210302145711
https://doi.org/10.2174/1573412917666210302145711
Autor:
Subrahmanyam Talari, Raju Moturu, S. N. Murthy Boddapati, Anuradha Vejendla, A. Emmanuel Kola
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-18 (2021)
Background Using a Symmetry C18 (4.6 × 150 mm, 3.5) column, a high-performance liquid chromatographic method for quantification of Rilpivirine and Cabotegravir in active pharmaceutical ingredients was developed and validated. The mobile phase is mad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f6d8f250daf05d5e8bffa813c1e7c0a
https://doaj.org/article/bb740d18053343ea90a656ec5ff22414
https://doaj.org/article/bb740d18053343ea90a656ec5ff22414
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 12:808-814
We have developed a completely unique and reliable HPLC technique for simultaneous quantification of Cisplatin and Topotecan. A chromatographic detachment was attained on a XDB C18 column (150x4.6mm, 3.5 µ) using isocratic elution with a buffer cont
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b94192de18682f6cf310651e97d5c17
https://doi.org/10.26452/ijrps.v12i1.4184
https://doi.org/10.26452/ijrps.v12i1.4184